Skip to main content

Profound Medical Corp.

PROF
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001628808

No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Profound Medical Corp. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of PROF: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders4443−1
Shares12.5M11.1M−1.42M (−11.4%)
Value$73.7M$54.3M−$19.4M (−26.3%)

New holders (5)

Institutions that held Profound Medical Corp. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to PROF in Q3 2025
InstitutionSharesValue% of portfolio
Rockefeller Capital Management L.P.6,654$32.5K0.00%
Tower Research Capital LLC (TRC)365$1.78K0.00%
CWM, LLC129$1.00K0.00%
Group One Trading, L.P.150$7470.00%
SBI Securities Co., Ltd.1$50.00%

Sold out (6)

Institutions that held Profound Medical Corp. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of PROF in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Picton Mahoney Asset Management254,329$1.50M
Alyeska Investment Group, L.P.160,000$944.0K
AYAL Capital Advisors Ltd41,308$243.7K
Neuberger Berman Group LLC12,300$72.6K
Carolina Wealth Advisors, LLC2,000$11.8K
Federation des caisses Desjardins du Quebec30$178